Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -48.50% | 33.31% | 227.27% | 499.11% | -58.00% |
Total Receivables | -38.22% | -5.32% | -45.66% | 122.55% | -23.01% |
Inventory | 12.54% | 1.86% | -0.82% | -0.04% | -22.61% |
Prepaid Expenses | -94.44% | -11.16% | 20.66% | 16.88% | -7.78% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -40.91% | -2.15% | 64.52% | 196.21% | -34.56% |
|
|||||
Total Current Assets | -40.91% | -2.15% | 64.52% | 196.21% | -34.56% |
Net Property, Plant & Equipment | -45.56% | 182.68% | 472.06% | 1,538.98% | 30.29% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -6.13% | 1.62% | 74.85% | 214.28% | -34.05% |
|
|||||
Total Accounts Payable | -23.94% | -36.50% | -18.11% | 117.40% | 130.11% |
Total Accrued Expenses | -- | -- | -- | 72.66% | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 11.67% | 1,462.86% | 3,709.41% | -- | 260.00% |
Total Finance Division Other Current Liabilities | -- | -- | -- | 237.50% | -- |
Total Other Current Liabilities | -- | -- | -- | 237.50% | -- |
Total Current Liabilities | 182.67% | 61.24% | 45.27% | 143.28% | 130.34% |
|
|||||
Total Current Liabilities | 182.67% | 61.24% | 45.27% | 143.28% | 130.34% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -73.99% | -61.13% | -52.05% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 181.62% | 60.60% | 44.48% | 143.93% | 131.29% |
|
|||||
Common Stock & APIC | 16.04% | 23.76% | 29.90% | 37.31% | 19.76% |
Retained Earnings | -31.71% | -28.24% | -28.19% | -31.44% | -32.97% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -1,179.88% | -245.01% | 238.98% | 547.65% | -118.76% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1,179.88% | -245.01% | 238.98% | 547.65% | -118.76% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1,179.88% | -245.01% | 238.98% | 547.65% | -118.76% |
|